3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
158
Lymphoma
156
Precursor Cell Lymphoblastic Leukemia-Lymphoma
130
Lymphoma, Non-Hodgkin
120
Leukemia
119
Leukemia, Lymphocytic, Chronic, B-Cell
116
Multiple Myeloma
115
Lymphoma, Large B-Cell, Diffuse
100
Leukemia, Myeloid, Acute
97
Hodgkin Disease
82
Myelodysplastic Syndromes
78
Lymphoma, Follicular
74
Lymphoma, Mantle-Cell
72
Burkitt Lymphoma
66
Lymphoma, B-Cell, Marginal Zone
52
Melanoma
49
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
48
Neoplasms
45
Recurrence
38
Hematologic Neoplasms
34
Lymphoma, Large-Cell, Immunoblastic
33
Myeloproliferative Disorders
31
Congenital Abnormalities
31
Waldenstrom Macroglobulinemia
30
Neoplasms, Plasma Cell
30
Leukemia, Myelomonocytic, Chronic
30
Lymphoma, B-Cell
29
Primary Myelofibrosis
27
Lymphoma, Large-Cell, Anaplastic
27
Leukemia, Myeloid, Accelerated Phase
26
Interventions
pazopanib
4
Doxorubicin
4
Sirolimus
3
Ifosfamide
3
Sorafenib
2
Radiotherapy
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
tazemetostat
1
sapanisertib
1
romidepsin
1
pexidartinib
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
indolepropanol phosphate
1
fludarabine phosphate
1
Watchful Waiting
1
Thiotepa
1
Tacrolimus
1
Sunitinib
1
Stem Cell Transplantation
1
STA 9090
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neurofibrosarcoma
×
Cyclophosphamide
×
Clear all
No trials found.